Logotype for Boundless Bio Inc

Boundless Bio (BOLD) Proxy filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Boundless Bio Inc

Proxy filing summary

28 Apr, 2026

Executive summary

  • The annual meeting will be held virtually on June 15, 2026, with a record date of April 20, 2026, for voting eligibility.

  • Stockholders will vote on the election of two Class II directors and the ratification of KPMG LLP as the independent auditor for 2026.

  • The board recommends voting in favor of all proposals.

  • Proxy materials are primarily distributed electronically to reduce costs and environmental impact.

Voting matters and shareholder proposals

  • Proposal 1: Elect James Christensen, Ph.D., and Jennifer Lew as Class II directors until 2029.

  • Proposal 2: Ratify KPMG LLP as independent auditor for the fiscal year ending December 31, 2026.

  • Stockholders may submit proposals for the 2027 meeting by December 30, 2026, for inclusion in proxy materials.

  • Advance notice procedures for director nominations and other proposals are detailed in the bylaws.

Board of directors and corporate governance

  • The board will decrease from seven to five members after the meeting, with staggered three-year terms for each class.

  • All directors except the CEO are considered independent under Nasdaq rules.

  • The board is chaired by an independent director, with separate CEO and chair roles.

  • Committees include Audit, Compensation, and Nominating and Corporate Governance, all with independent members.

  • The board encourages diversity, independence, and relevant expertise in director selection.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more